New insights on interactions between HIV-1 and HSV-2

被引：13

作者：

Delany-Moretlwe S. ^{[1
]}

Lingappa J.R. ^{[1
]}

Celum C. ^{[1
]}

机构：

[1] Reproductive Health and HIV Research Unit, University of Witwatersrand, Hillbrow, Johannesburg 2038

来源：

Current Infectious Disease Reports | 2009年 / 11卷 / 2期

关键词：

Acyclovir;

D O I：

10.1007/s11908-009-0020-8

中图分类号：

学科分类号：

摘要：

Herpes simplex type 2 (HSV-2) infection is common and frequently asymptomatic. Concerns exist about the high prevalence of HSV-2, particularly in areas of high HIV prevalence, because of observations that HSV-2 is associated with an increased risk of HIV acquisition, transmission, and disease progression. Several randomized trials have tested or are testing whether HSV-2 treatment can limit the spread of HIV, with mixed results. Although treatment with acyclovir, 400 mg twice daily, does not reduce HIV incidence, suppressive acyclovir and valacyclovir reduce HIV levels in plasma and in the genital tract. Ongoing trials are evaluating whether HSV suppression will reduce HIV transmission and disease progression. Until a protective HSV-2 or HIV vaccine is available, effective interventions that reduce the effect of HSV-2 on HIV transmission are critically needed. © Current Medicine Group, LLC 2009.

引用

页码：135 / 142

页数：7

共 58 条

[11]

Corey L., Wald A., Celum C.L., Quinn T.C., The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: A review of two overlapping epidemics, J Acquir Immune Defic Syndr, 35, pp. 435-445, (2004)

[12]

Freeman E.E., Weiss H.A., Glynn J.R., Et al., Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies, AIDS, 20, pp. 73-83, (2006)

[13]

Brown J.M., Wald A., Hubbard A., Et al., Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe, AIDS, 21, pp. 1515-1523, (2007)

[14]

Koelle D.M., Abbo H., Peck A., Et al., Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions, J Infect Dis, 169, pp. 956-961, (1994)

[15]

Rebbapragada A., Wachihi C., Pettengell C., Et al., Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract, AIDS, 21, pp. 589-598, (2007)

[16]

Zhu J., Koelle D.M., Cao J., Et al., Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation, J Exp Med, 204, pp. 595-603, (2007)

[17]

Watson-Jones D., Weiss H.A., Rusizoka M., Et al., Effect of herpes simplex suppression on incidence of HIV among women in Tanzania, N Engl J Med, 358, pp. 1560-1571, (2008)

[18]

Mark K.E., Wald A., Magaret A.S., Et al., Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults, J Infect Dis, 198, pp. 1141-1149, (2008)

[19]

Posavad C.M., Wald A., Kuntz S., Et al., Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy, J Infect Dis, 190, pp. 693-696, (2004)

[20]

Strick L.B., Wald A., Celum C., Management of herpes simplex virus type 2 infection in HIV type 1-infected persons, Clin Infect Dis, 43, pp. 347-356, (2006)

← 1 2 3 4 5 6 →